INTRODUCTION
The newborn infant has certain disadvantages when compared to adults in maintaining a normal body temperature. The importance of nurturing the preterm and sick term neonate in a thermal neutral environment was recognized late in the 1800s. 1 The advantages of`i solation'' to provide adequate heat, humidity, and prevent infections was developed in the mid-20th century and represents an advance in neonatal medicine that reduced significant infant mortality. 2, 3 More recently, studies have demonstrated that hyperthermia, hypothermia, and the hazards of rewarming may be of critical importance to such outcome variables as weight gain, respiratory status, and neurologic sequelae. 4, 5 Complex devices with servocontrolled mechanisms have been developed to achieve stability in populations of preterm and sick term babies. 2, 3, 6, 7 Two different warming modalities are currently used in the neonatal intensive care unit (NICU). The radiant warmer is an open-bed frame with a radiant (electrically heated metal alloy wire coiled within a quartz tube) heat source suspended approximately 90 cm above. This heats the baby through radiation and allows immediate contact with the infant. Although allowing for immediate access for critical care management, the disadvantages of having an infant lie on an open bed include fluid and heat loss to convection and evaporation, exposure to the environment, and a lack of a barrier to infection. Incubation, therefore, is the modality of choice for the sick or preterm infant in need of warmth in whom less immediate access is needed. Incubators function by providing convective heat (and possibly humidity) to the infant in an enclosed environment.
Though often a matter of``style,'' the warmer is generally preferred in the unstable infant so as to permit rapid access. The disadvantages of this device, which include limitations in environmental and humidity control, necessitate the eventual transfer of the infant to an incubator. Once in an incubator the infant is occasionally returned to a warmer bed for procedures, or if they become unstable (i.e., new infection or increased respiratory distress) and the need for rapid access is anticipated.
The transition between these modes of warmer has not been previously evaluated. During the transition the infant is disturbed, removed from the thermal neutral environment, and placed in the nearby, prewarmed device. This transition would increase heat loss, and potentially result in the need for rewarming the infant. In addition, moving a critically ill infant poses risks including line
OBJECTIVE:
The use of both warmer beds and incubators is common in neonatal intensive care units ( NICU ) , and transferring between these two warming devices is a routine and necessary event. This study was designed to evaluate the efficacy of a new hybrid -warming device, the Versalet 2 , in transitioning a preterm animal from a warmer bed to an incubator mode and back.
STUDY DESIGN:
Nine premature lambs were randomized, following delivery, to receive thermal support from a conventional warming bed and an incubator ( control group ) , or from the Versalet 2 ( study group ) in the warmer bed and incubator modes. Core and various surface temperatures, as well as physiological parameters were measured first during warming in the radiant warmer bed mode, Versalet 2 or Resuscitaire 2 and then during transition to the incubator mode, Versalet 2 or Isolette 2 , and then back to the warmer bed mode.
RESULTS:
The animals remained stable during all the transitions. Despite careful planning, adverse events occurred in the control group during transfers. There were no significant differences in the temperature or physiologic profiles during any of the transitions in either group.
CONCLUSION:
Compared with the standard warming technique used in NICUs ( separate warmer bed and incubator ) , the Versalet provides similar thermal and cardiovascular stability without adverse events during transition to different modes of warming. The degree to which this device would contribute to ease of management and improved outcomes in humans needs to be evaluated in a clinical trial. Original Article Figure 1A and B) . We evaluated the effectiveness of this device in a preterm animal preparation. We hypothesized that this hybrid device would maintain thermal stability, ease of transfer between warming modalities, and decrease adverse events during this transition, which may result in a safer and less stressful transition.
MATERIALS AND METHODS Animal Preparation
Nine premature twin gestation lambs were at 1273 days' gestation (term=147 days gestation). All animals were managed according to the regulations of the National Institutes of Health regulations and the Physiological Society. In addition, the Institutional Animal Care Use Committee of Temple University School of Medicine approved all procedures.
As previously described, 8 ± 10 dated pregnant ewes were administered ketamine (1.5 mg/kg) pre-anesthesia, followed by epidural anesthesia induction with 0.5 to 1.0 mg/kg 0.75% bupivacaine. The ewe was blindfolded and restrained in a prone position and a Cesarean section was carried out through the ventrolateral approach. After exposure of the uterus, a hysterotomy was performed and the head of the lamb was delivered. Following local anesthesia with 1% lidocaine a 5 FR umbilical catheter was placed in the carotid artery for blood pressure monitoring and sampling for arterial blood chemistry, and a 5 FR thermodilation catheter was placed in the jugular vein for fluid management and central blood temperature measurement. A tracheotomy was carried out and an endotracheal tube was inserted into the trachea. Baseline blood chemistries were obtained and the lamb was delivered, dried, weighed, and immediately supported with conventional mechanical ventilation.
All lambs were managed using techniques to insure a pain-free experimental period. A 10% dextrose infusion was given through the venous catheter and heparinized normal saline was infused through the arterial catheter to maintain a normal glucose level. Lambs were ventilated using a time-cycled, pressure-limited gas ventilator (Infant Star 2 ; Infrasonics, San Diego, CA and SLE 2000, Infant Ventilator, UK). Lambs were treated with exogenous surfactant (Survanta 2 ; 4 ml/kg; Ross Laboratories), within the first 30 minutes following delivery if respiratory compliance was <0.30 ml/ cm H 2 0 per kilogram as determined by airway manometry and pneumotachography (Peds 2 , MAS, Hatfield, PA). Ventilator settings were adjusted to maintain the arterial PaCO 2 of 40 to 50 mm Hg and PaO 2 >100 mm Hg, which were measured every 15 minutes (Radiometer; ABL 330). Donor sheep blood was given if necessary to maintain stable hematocrit. Blood pressure and heart rate were monitored continuously with an Athena cardiorespiratory monitor.
Experimental Design
Preterm animals were randomized to either the Versalet 7700 Care System 2 (study group, n=5) or the combination of the 
Control Group
Following birth, animals were transferred to the Resuscitaire 2 infant radiant warmer preheated to 388C. The animal was placed on the bedside monitor, temperature probes and intravascular catheters were secured, and baseline temperatures and vital sign values were recorded. The heater output adjusted (servo controlled) to maintain the external skin temperature at 3880.58C. Temperature values were recorded every 2 minutes while the animal was managed on the warmer until the set temperature was maintained for 15 minutes. The animal was then transferred to the incubator that had been preheated to 388. All doors and side ports were closed and the animal remained in this device until the external skin temperature was maintained at 388C0.58C for 15 minutes in the servo-control mode for this device (warmer to incubator test).
Once maintained within 0.58C of the set temperature of 388C, the process was reversed and the animal was returned from the incubator to the warmer (incubator to warmer bed mode test). This test was completed when the animal's temperature was maintained to within 0.58C of the set temperature of 388C for 15 minutes.
Study Group
The Versalet 2 is a hybrid between the Isolette and radiant warmer ( Figure 1A and B) . When in the incubator mode the radiant heating element is turned off and the incubator convective heater is on. Upon transition to the warming mode the radiant heating element is activated and the convective element is diminished. A low power level for the convective heater is maintained while the Versalet 2 is in the warmer mode to allow for a stable transition to the incubator mode.
Similar procedures were followed in the study animals with the Versalet 2 during warmer bed test (closed mode) and the incubator (open mode) as in the control animals for the Resuscitaire 2 infant radiant warmer and the C550 infant Isolette 2 . Following delivery, if randomized to the study group, the lamb was placed in the Versalet in the open bed mode ( Figure 1A ). They were connected to the bedside monitor, and temperature probes and intravascular catheters were secured. Baseline temperature and vital sign values were recorded. Temperature was set at 388C on the Versalet 2 and the device adjusted its heater output to achieve an external skin temperature of 3880.58C. The subject was managed in this mode of warming (warmer bed) until the set temperature was maintained for 15 minutes; temperature values were recorded every 2 minutes. At this time the overhead radiant warmer was lowered, sides raised, and canopies were closed for the transition into the incubator mode of the Versalet ( Figure 1B) . The external skin temperature was maintained and the device was reset to servo-control the incubator mode set temperature of 3880.58C. The warmer to incubator test was completed when the skin temperature was maintained for 15 minutes.
The animal was then changed from the incubator mode back to warmer bed mode. At this point the side walls were lowered, and the overhead portion was raised to the fully upright position. When fully elevated, the radiant heater was triggered to keep the external skin temperature probe within 0.58 of the 388C set point by servo-control. This test was completed when the animal's temperature was maintained for 15 minutes.
Statistical Analysis
The differences between physiologic and thermal parameters were compared between the two groups by Student's t-test. Significance was accepted to the p<0.05 level.
RESULTS
Five sets of preterm lambs were evaluated. One lamb died before entry into the study. The five study lambs (weight 3371252 SD g) and four control lambs (weight 3603303 SD g) each tolerated the protocol. Several adverse events were recorded in the control animals, including displacement of several support lines (arterial and venous catheters, and EKG leads) and transient loss of monitoring during transition. In addition the control group transfers required much more manpower, as several members (three to four) of the team were required to minimize disruption, speed the transfer, and carry equipment.
The change in temperature during the two control tests (warmer bed to incubator mode, and incubator to warmer bed mode) for the measured temperatures are depicted in Figure 2A± D. These values can be compared to the change in temperature during the tests in the Versalet (warmer bed mode to incubator mode, and incubator mode to warmer bed mode; Figure 3A±D ). As shown, there was a modest increase in the blood temperature (measured with a central catheter-thermister) during the entire procedure in both groups. This finding was due to the natural tendency to warm over time to 388C in this animal population. No thermal or physiologic instability was seen in lambs during any of the transitions. The rectal, head, and abdominal skin temperatures were relatively well preserved during each transition, and there were no significant differences in temperatures between groups at any time point. The peripheral skin temperature fluctuated during the transition in each group. 
and heart rate (HR) for control animals for the transition from the control group in transition from warmer bed mode to incubator mode (A), and back to warmer bed mode (B). These same changes are shown in the study animals from the warmer bed to incubator mode in the Versalet (C), and from incubator to warmer bed mode in the Versalet 2 (D). There were no significant changes in any of these parameters during any transition.
The changes in physiological parameters before and after the transitions in both the control and study modes are depicted in Figure 4A±D . As shown, there were no significant differences in vital signs or gas exchange during the transition.
COMMENTS
In the present study a new hybrid device is tested that provides the capability to warm an infant in either a radiant-warmer bed or a convective-warming incubator mode. The tested animal population simulates the newborn preterm neonate. When utilizing the Versalet 2 , the transition between warming modalities occurs with the subject in the device, and no patient movement is required. The numerous potential advantages of this system have to be countered by the potential safety concerns if a smooth transition of heat production between the two outputs cannot be efficiently coordinated.
The evaluation of this transition is extremely important in evaluating such a hybrid device. If an infant were to experience a hypothermic event during the transition, significant adverse events could occur that might not be present when moving to a preheated device. The radiant heat source cannot be turned on while the infant is in the incubator mode, and the convective heater cannot warm the surrounding air while in the incubator mode when utilizing the Versalet 2 . Hence, there is a potential delay in heater output and warming during this transition, which could lead to thermal instability. The degree to which either transition leads to acute thermal instability is critical, not only for the period of hypothermia, but also for the requirement of rewarming. The rewarming process is potentially complicated, and may result in a period prolonged hypothermia if the heater output is too low, or overshoot overheating if the output is too high or the sensitivity of the servo control is inadequate to compensate. The Versalet 2 has been designed to minimize the transition time between modalities, thereby reducing temperature loss and the risk for hypothermia and the need for rewarming.
The thermal studies presented herein indicate that both groups of animals transitioned very similarly between the two different modalities. Both the study and control modalities produced thermal stability in core temperature (as measured by rectal and central blood temperature) during transition from different modes of warming. No significant differences were seen in any of the measured temperature parameters (head, abdomen, leg, rectum, or blood). Some of the fluctuations in these parameters were likely due to thermister placement, and regional variations in perfusion. The transition of all animals in this study was performed effectively, with little change in temperature and stability of vital signs. Hence, all of the devices tested provided effective thermal stability with minimum heat loss during transition from a thermal neutral environment. Furthermore, any small fluctuations in temperature were well tolerated and recovered quickly. Adverse events in the form of dislodged support lines occurred only in the control group. Because more temperature probes were utilized on these animals than would be clinically applicable, some excess risk of entanglement was anticipated. Loss of the excess temperature probes was not documented as an adverse event. It should be noted, however, that this transition was preplanned and orchestrated. For the control group, the devices were fully preheated and positioned immediately next to each other, with the transition taking only a few seconds. This scenario is rarely present in the hurried NICU environment, and thermal stability may not be maintained as well in the clinical environment.
This study indicates that the new hybrid device, the Versalet 2 , appears to be effective at providing steady-state servo-controlled thermal support to this preterm animal population that simulates a sick newborn preterm human. In addition, the Versalet 2 offers effective steady-state temperature control, with fewer adverse events during transitions, when compared to transitions utilizing two preheated devices. The degree to which this device would contribute to ease of management and improved outcomes in humans needs to be evaluated in a clinical trial.
